R. Michael Carruthers - 28 May 2025 Form 4 Insider Report for OnKure Therapeutics, Inc. (OKUR)

Reporting relationship: Director
Issuer ticker: OKUR
Reported as of: 28 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 30 May 2025, 16:50:10 UTC
Prior SEC filing: 07 May 2025
Next SEC filing: 09 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Rogan Nunn, by power of attorney

Key filing fact

R. Michael Carruthers filed Form 4 for OnKure Therapeutics, Inc. (OKUR) on 30 May 2025.

Key facts

This page summarizes R. Michael Carruthers's Form 4 filing for OnKure Therapeutics, Inc. (OKUR).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 30 May 2025, 16:50.

Change

Previous filing in this sequence was filed on 07 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001644467 Primary reporting owner

Carruthers R Michael

Relationship: Director
Address: C/O ONKURE THEREAPEUTICS, INC., 6707 WINCHESTER CIRCLE, SUITE 400, BOULDER
Signature: /s/ Rogan Nunn, by power of attorney
Signature date: 30 May 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OKUR transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +7,650
Change %
Price: $0.000000
Shares after: 7,650
Date: 28 May 2025
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 7,650
Exercise price: $2.44
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

100% of the shares subject to the option will vest on the earlier of May 28, 2026 or the day prior to the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through the applicable vesting date.